4,897 followers
New Research: Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients: Background Sodium–glucose co-transporter 2 (SGLT2) inhibitors provide cardiovascular protection for patients with heart failure… https://t.co/Z93dwwVA